Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. It develops antibody therapies for the treatment of autoimmune diseases and cancer, with its work primarily focused on the development of orphan drugs. This description is adapted from Wikipedia contributors under CC BY-SA 4.0; changes were made. https://creativecommons.org/licenses/by-sa/4.0/
Facts
Company Type Founded Year Company Type
Company Type (category) Connections
Operates In
Source Wikipedia: Argenx
In the Other Atlases
Located In
Also in Geography Atlas: where this subject is located.
Source Wikipedia: Argenxtier 2
Also in Geography Atlas: where this subject is located.
Source Wikipedia: Argenxtier 2
Sources
1. Argenx (Wikipedia)
Lead section
Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer.
Infobox: founded
2008
View the SourceWikipedia: Argenx
WikipediaOperates In: Biotechnology Industry, Infobox: industryQuote, Operates In: Biotechnology Industry, Infobox: industry
Biotechnology
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.